CDAK
UBS Group’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-91
| Closed | -$16 | – | 9110 |
|
|
2023
Q1 | $16 | Hold |
91
| – | – | ﹤0.01% | 8338 |
|
|
2022
Q4 | $36 | Sell |
91
-159
| -64% | -$63 | ﹤0.01% | 9310 |
|
|
2022
Q3 | $0 | Sell |
250
-366
| -59% | – | ﹤0.01% | 10165 |
|
|
2022
Q2 | $2K | Buy |
+616
| New | +$2K | ﹤0.01% | 8681 |
|
|
2022
Q1 | – | Sell |
-3,722
| Closed | -$41K | – | 9968 |
|
|
2021
Q4 | $41K | Sell |
3,722
-1,878
| -34% | -$20.7K | ﹤0.01% | 6003 |
|
|
2021
Q3 | $91K | Sell |
5,600
-1,900
| -25% | -$30.9K | ﹤0.01% | 4820 |
|
|
2021
Q2 | $139K | Sell |
7,500
-252
| -3% | -$4.67K | ﹤0.01% | 4596 |
|
|
2021
Q1 | $116K | Sell |
7,752
-831
| -10% | -$12.4K | ﹤0.01% | 4872 |
|
|
2020
Q4 | $278K | Buy |
+8,583
| New | +$278K | ﹤0.01% | 4070 |
|